121 related articles for article (PubMed ID: 38811250)
1. Hematuria Cancer Risk Score with Ultrasound Informs Cystoscopy Use in Patients with Hematuria.
Tan WS; Ahmad A; Zhou Y; Nathan A; Ogunbo A; Gbolahan O; Kallam N; Smith R; Khalifeh M; Tan WP; Cohen D; Volanis D; Walter FM; Sasieni P; Kamat AM; Kelly JD
Eur Urol Oncol; 2024 May; ():. PubMed ID: 38811250
[TBL] [Abstract][Full Text] [Related]
2. Can Renal and Bladder Ultrasound Replace Computerized Tomography Urogram in Patients Investigated for Microscopic Hematuria?
Tan WS; Sarpong R; Khetrapal P; Rodney S; Mostafid H; Cresswell J; Hicks J; Rane A; Henderson A; Watson D; Cherian J; Williams N; Brew-Graves C; Feber A; Kelly JD;
J Urol; 2018 Nov; 200(5):973-980. PubMed ID: 29702097
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer.
Tan WS; Ahmad A; Feber A; Mostafid H; Cresswell J; Fankhauser CD; Waisbrod S; Hermanns T; Sasieni P; Kelly JD;
J Intern Med; 2019 Apr; 285(4):436-445. PubMed ID: 30521125
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
Blick CG; Nazir SA; Mallett S; Turney BW; Onwu NN; Roberts IS; Crew JP; Cowan NC
BJU Int; 2012 Jul; 110(1):84-94. PubMed ID: 22122739
[TBL] [Abstract][Full Text] [Related]
5. A urinary assay for mutation and methylation biomarkers in the diagnosis and recurrence prediction of non-muscle invasive bladder cancer patients.
Huang H; Liu A; Liang Y; Xin Y; Liu J; Hao Y; Huang D; Chen L; Li W; Jiang G; Huang Y; Xu Y; Zhang J; Ma T; Xu D; Gao Y
BMC Med; 2023 Sep; 21(1):357. PubMed ID: 37726806
[TBL] [Abstract][Full Text] [Related]
6. A simplified nomogram to assess risk of bladder cancer in patients with a new diagnosis of microscopic hematuria.
Matulewicz RS; Rademaker A; Meeks JJ
Urol Oncol; 2020 Apr; 38(4):240-246. PubMed ID: 31952999
[TBL] [Abstract][Full Text] [Related]
7. A Urine Based Genomic Assay to Triage Patients with Hematuria for Cystoscopy.
van Kessel KEM; de Jong JJ; Ziel-van der Made ACJ; Roshani H; Haensel SM; Wolterbeek JH; Boevé ER; Oomens EHGM; van Casteren NJ; Krispin M; Boormans JL; Steyerberg EW; van Criekinge W; Zwarthoff EC
J Urol; 2020 Jul; 204(1):50-57. PubMed ID: 31985322
[TBL] [Abstract][Full Text] [Related]
8. Who needs an ultrasound? Using patient symptom questionnaire & UTI history to determine when to obtain an RBUS in children with non-neurogenic lower urinary tract dysfunction.
Fischer KM; Samet E; Messina A; Berry A; Zderic SA; Van Batavia JP
J Pediatr Urol; 2023 Oct; 19(5):542.e1-542.e7. PubMed ID: 37537092
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of ultrasonography, computed tomography, cystoscopy and cytology to detect urinary tract malignancies in patients with asymptomatic hematuria.
Fankhauser CD; Waisbrod S; Fierz C; Becker AS; Kranzbühler B; Eberli D; Sulser T; Mostafid H; Hermanns T
World J Urol; 2021 Jan; 39(1):97-103. PubMed ID: 32240349
[TBL] [Abstract][Full Text] [Related]
10. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
van Kessel KE; Beukers W; Lurkin I; Ziel-van der Made A; van der Keur KA; Boormans JL; Dyrskjøt L; Márquez M; Ørntoft TF; Real FX; Segersten U; Malats N; Malmström PU; Van Criekinge W; Zwarthoff EC
J Urol; 2017 Mar; 197(3 Pt 1):590-595. PubMed ID: 27746284
[TBL] [Abstract][Full Text] [Related]
11. Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay)--useful diagnostic tools in the diagnosis of urinary bladder cancer?
Mahnert B; Tauber S; Kriegmair M; Nagel D; Holdenrieder S; Hofmann K; Reiter W; Schmeller N; Stieber P
Clin Chem Lab Med; 2003 Jan; 41(1):104-10. PubMed ID: 12636058
[TBL] [Abstract][Full Text] [Related]
12. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
[TBL] [Abstract][Full Text] [Related]
13. A Genomic Urine Assay for Surveillance of Patients with Bladder Cancer Treated with Radiotherapy.
de Jong FC; Iflé IG; van der Made AC; Kooper D; de Jong JJ; Franckena M; Zuiverloon TCM; van Criekinge W; Incrocci L; Zwarthoff EC; Boormans JL
Eur Urol Open Sci; 2024 Apr; 62():131-139. PubMed ID: 38496820
[TBL] [Abstract][Full Text] [Related]
14. Hematuria screening test for urinary bladder mucosal infiltration in cervical cancer.
Chuttiangtum A; Udomthavornsuk B; Chumworathayi B
Asian Pac J Cancer Prev; 2012; 13(10):4931-3. PubMed ID: 23244084
[TBL] [Abstract][Full Text] [Related]
15. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
16. NMP22: a sensitive, cost-effective test in patients at risk for bladder cancer.
Zippe C; Pandrangi L; Potts JM; Kursh E; Novick A; Agarwal A
Anticancer Res; 1999; 19(4A):2621-3. PubMed ID: 10470205
[TBL] [Abstract][Full Text] [Related]
17. DETECT I & DETECT II: a study protocol for a prospective multicentre observational study to validate the UroMark assay for the detection of bladder cancer from urinary cells.
Tan WS; Feber A; Dong L; Sarpong R; Rezaee S; Rodney S; Khetrapal P; de Winter P; Ocampo F; Jalil R; Williams NR; Brew-Graves C; Kelly JD
BMC Cancer; 2017 Nov; 17(1):767. PubMed ID: 29141603
[TBL] [Abstract][Full Text] [Related]
18. Virtual cystoscopy of the contrast material-filled bladder in patients with gross hematuria.
Kim JK; Ahn JH; Park T; Ahn HJ; Kim CS; Cho KS
AJR Am J Roentgenol; 2002 Sep; 179(3):763-8. PubMed ID: 12185059
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic performance of ultrasound for macroscopic hematuria in the era of multidetector computed tomography urography.
Rhéaume-Lanoie J; Lepanto L; Fradet V; Billiard JS; Tang A
Can Assoc Radiol J; 2014 Aug; 65(3):253-9. PubMed ID: 24316140
[TBL] [Abstract][Full Text] [Related]
20. Validation of an mRNA-based Urine Test for the Detection of Bladder Cancer in Patients with Haematuria.
Valenberg FJPV; Hiar AM; Wallace E; Bridge JA; Mayne DJ; Beqaj S; Sexton WJ; Lotan Y; Weizer AZ; Jansz GK; Stenzl A; Danella JF; Cline KJ; Williams MB; Montgomery S; David RD; Harris R; Klein EW; Bradford TJ; Wolk FN; Westenfelder KR; Trainer AF; Richardson TA; Egerdie RB; Goldfarb B; Zadra JA; Lu X; Simon IM; Campbell SA; Bates MP; Higuchi RG; Witjes JA
Eur Urol Oncol; 2021 Feb; 4(1):93-101. PubMed ID: 33004290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
